Successful treatment of acute kidney allograft rejection using extracorporeal photopheresis in the context of post-transplant lymphoproliferative diseases: three successive cases

Transpl Int. 2021 Nov;34(11):2415-2417. doi: 10.1111/tri.14006. Epub 2021 Sep 5.

Abstract

We reported 3 kidney transplant patients with PTLD who developed mixed AR following IS treatment minimization. AR episodes were treated with extracorporeal photopheresis (ECP), methylprednisolone and IVIG. In all patients, graft function improved under ECP and stabilized in the long term. These observations suggest that ECP is safe and efficient for treatment of AR in the context of PTLD.

Publication types

  • Letter

MeSH terms

  • Allografts
  • Graft Rejection / therapy
  • Humans
  • Kidney
  • Kidney Transplantation* / adverse effects
  • Photopheresis*